Bioasis Technologies Inc.
BIOAF · OTC
11/30/2022 | 8/31/2022 | 5/31/2022 | 2/28/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 23.7% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | -$0 | -$0 |
| % Margin | -48.3% | 74% | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $0 | $1 |
| SG&A Expenses | $1 | $1 | $0 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | -$1 | -$1 | -$1 | -$2 |
| % Margin | -469.2% | -747% | – | – |
| Other Income/Exp. Net | -$0 | -$0 | $0 | $0 |
| Pre-Tax Income | -$1 | -$1 | -$0 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$1 | -$0 | -$1 |
| % Margin | -661.8% | -905.2% | – | – |
| EPS | -0.013 | -0.014 | -0.003 | -0.008 |
| % Growth | 9.4% | -334.4% | 59% | – |
| EPS Diluted | -0.013 | -0.014 | -0.003 | -0.008 |
| Weighted Avg Shares Out | 78 | 78 | 73 | 73 |
| Weighted Avg Shares Out Dil | 78 | 78 | 73 | 73 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | $0 | -$2 |
| % Margin | -445.8% | -688% | – | – |